FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutical industry, and concerns an immunomodulatory drug preparation showing antiviral properties. Substance of the invention consists in the fact that the offered drug preparation contains sodium nucleinate 2 to 50 mg/ml, sodium chloride 3 to 10 mg/ml and apyrogenic water with pH making within 6.0 to 7.5.
EFFECT: preparation has a direct antiviral effect, suppresses reproductive ability of viruses.
2 cl, 3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED VACCINE FOR THE IMMUNOPROPHYLAXIS OF MEASLES, CONTAGIOUS PAROTITIS AND RUBELLA | 2016 |
|
RU2657801C1 |
| METHOD OF DETERMINING BIOLOGICAL ACTIVITY OF MEASLES, EPIDEMIC PAROTITIS AND RUBELLA DURING PRODUCTION OF ASSOCIATED PREPARATIONS (VERSIONS) | 2015 |
|
RU2606848C2 |
| METHOD OF TREATMENT OF CHILDREN WITH PAROTIC ORCHITIS | 1997 |
|
RU2154493C2 |
| DRUG PREPARATION SHOWING ANTICANCER PROPERTIES | 2010 |
|
RU2443411C1 |
| LINE OF DUPLEX FIBROBLAST CELLS OF EASY HUMAN EMBRYO FOR ALLOCATION, IDENTIFICATIONS OF VIRUSES AND OBTAINING OF DIAGNOSTIC AND VACCINAL PREPARATIONS | 2006 |
|
RU2343194C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ENZYME RIBONUCLEASE AND GLYCYRRHIZIC ACID OR SALTS THEREOF: AMMONIUM OR DIPOTASSIUM OR TRISODIUM GLYCYRRHIZINATE | 2012 |
|
RU2504397C1 |
| METHOD OF PRODUCING FOUR-COMPONENT LIVE CULTURE VACCINE AGAINST MEASLES, VARICELLA, MUMPS, AND RUBELLA | 2019 |
|
RU2717769C1 |
| METHOD FOR ANALYSING AND PREDICTING DEVELOPMENT OF EPIDEMICAL SITUATION CAUSED BY SOCIALLY MINDED AIRBORNE INFECTIONS | 2014 |
|
RU2572227C2 |
| METHOD OF USING Bacillus intermedius RIBONUCLEASE | 2012 |
|
RU2509801C2 |
| METHOD FOR DIAGNOSING EPIDEMIC PAROTITIS | 2022 |
|
RU2785486C1 |
